MedPath

CLADRIBINE INJECTION

CLADRIBINE INJECTION

Approved
DIN Number

02319918

Drug Class

Human

Market Date

Jun 30, 2009

Company
HC

fresenius kabi canada ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02319918
AIG Number0124270001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01BB04 CLADRIBINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CLADRIBINEActive
Strength: 1 MG / ML
Monograph: CLADRIBINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.